Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Apr-24 4:42 PM View:  | Nsv Partners III Lp 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 12-Apr-24 | Disposition (other) | 695,339 | -- | -- | (8%) 8.44M to 7.74M | |
| 16-Apr-24 4:50 PM View: | Subramaniam Somu Director 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 12-Apr-24 | Disposition (other) Duplicate | 695,339 | -- | -- | (8%) 8.44M to 7.74M | |
| 03-Apr-24 7:30 PM View: | Auster Martin Chief Financial Officer | Ventyx Biosciences, Inc. (VTYX) | 02-Apr-24 | Sale | 1,405 | $5.40 | $7,591.92 | (5%) 25.71K to 24.3K | |
| 03-Apr-24 7:33 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 02-Apr-24 | Sale | 1,651 | $5.40 | $8,921.01 | (< 1%) 266.65K to 265.0K | |
| 03-Apr-24 7:32 PM View: | Mohan Raju CEO and President Director | Ventyx Biosciences, Inc. (VTYX) | 02-Apr-24 | Sale | 4,312 | $5.40 | $23,299.50 | (< 1%) 1.58M to 1.58M | |
| 03-Apr-24 7:37 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 02-Apr-24 | Sale | 1,651 | $5.40 | $8,921.34 | (< 1%) 286.65K to 285.0K | |
| 29-Mar-24 6:07 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 28-Mar-24 | Option Exercise | 4,531 | -- | -- | 2% 262.12K to 266.65K | |
| 29-Mar-24 6:09 PM View: | Mohan Raju CEO and President Director | Ventyx Biosciences, Inc. (VTYX) | 28-Mar-24 | Option Exercise | 11,843 | -- | -- | < 1% 1.57M to 1.58M | |
| 29-Mar-24 6:15 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 28-Mar-24 | Option Exercise | 4,531 | -- | -- | 2% 282.12K to 286.65K | |
| 29-Mar-24 6:12 PM View: | Auster Martin Chief Financial Officer | Ventyx Biosciences, Inc. (VTYX) | 28-Mar-24 | Option Exercise | 4,531 | -- | -- | 21% 21.18K to 25.71K | |
| 21-Dec-23 8:12 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 20-Dec-23 | Sale | 5,293 | $2.12 | $11,210.00 | (2%) 287.41K to 282.12K | |
| 21-Dec-23 8:14 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 20-Dec-23 | Sale | 17,628 | $2.12 | $37,334.30 | (6%) 279.75K to 262.12K | |
| 21-Dec-23 8:10 PM View: | Mohan Raju CEO and President Director | Ventyx Biosciences, Inc. (VTYX) | 20-Dec-23 | Sale | 58,860 | $2.12 | $124,660.00 | (4%) 1.63M to 1.57M | |
| 19-Dec-23 5:27 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 17-Dec-23 | Option Exercise | 34,931 | -- | -- | 14% 244.81K to 279.75K | |
| 19-Dec-23 5:30 PM View: | Mohan Raju CEO and President Director | Ventyx Biosciences, Inc. (VTYX) | 17-Dec-23 | Option Exercise | 116,668 | -- | -- | 8% 1.51M to 1.63M | |
| 19-Dec-23 5:25 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 17-Dec-23 | Option Exercise | 10,479 | -- | -- | 4% 276.93K to 287.41K | |
| 11-Oct-23 4:21 PM View: | Nsv Partners III Lp 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 09-Oct-23 | Private Sale (Planned) Duplicate | 49,152 | $30.03 | $1,475,860.00 | (< 1%) 8.49M to 8.44M | |
| 11-Oct-23 4:18 PM View: | Subramaniam Somu Director 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 09-Oct-23 | Private Sale (Planned) | 49,152 | $30.03 | $1,475,860.00 | (< 1%) 8.49M to 8.44M | |
| 06-Oct-23 7:16 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 05-Oct-23 | Planned Option Sale | 30,000 | $29.11 | $873,231.00 | (2%) 1.54M to 1.51M | |
| 06-Oct-23 7:16 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 05-Oct-23 | Option Exercise | 30,000 | $8.04 | $241,200.00 | 2% 1.51M to 1.54M | |
| 04-Oct-23 7:26 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Oct-23 | Planned Option Sale | 10,000 | $29.99 | $299,933.00 | (4%) 254.81K to 244.81K | |
| 04-Oct-23 7:33 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Oct-23 | Planned Option Sale | 15,000 | $29.98 | $449,699.00 | (5%) 291.55K to 276.55K | |
| 04-Oct-23 7:26 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Oct-23 | Option Exercise | 10,000 | $3.35 | $33,542.20 | 4% 244.81K to 254.81K | |
| 04-Oct-23 7:33 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Oct-23 | Option Exercise | 15,000 | $8.04 | $120,600.00 | 5% 276.55K to 291.55K | |
| 20-Sep-23 7:16 PM View: | Nsv Partners III Lp 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 18-Sep-23 | Private Sale (Planned) | 56,665 | $37.81 | $2,142,630.00 | (< 1%) 8.55M to 8.49M | |
| 20-Sep-23 7:19 PM View: | Subramaniam Somu Director 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 18-Sep-23 | Private Sale (Planned) Duplicate | 56,665 | $37.81 | $2,142,630.00 | (< 1%) 8.55M to 8.49M | |
| 07-Sep-23 4:28 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Planned Option Sale | 15,000 | $32.61 | $489,109.00 | (5%) 291.55K to 276.55K | |
| 07-Sep-23 4:21 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Option Exercise | 10,000 | $0.20 | $2,000.00 | 4% 244.81K to 254.81K | |
| 07-Sep-23 4:31 PM View: | Auster Martin Chief Financial Officer | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Private Sale (Planned) | 26,472 | $32.61 | $863,334.00 | (56%) 47.65K to 21.18K | |
| 07-Sep-23 4:28 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Option Exercise | 15,000 | $8.04 | $120,600.00 | 5% 276.55K to 291.55K | |
| 07-Sep-23 4:25 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Planned Option Sale | 30,000 | $32.61 | $978,343.00 | (2%) 1.54M to 1.51M | |
| 07-Sep-23 4:21 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Planned Option Sale | 10,000 | $32.60 | $325,960.00 | (4%) 254.81K to 244.81K | |
| 07-Sep-23 4:25 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 05-Sep-23 | Option Exercise | 30,000 | $8.04 | $241,200.00 | 2% 1.51M to 1.54M | |
| 01-Sep-23 4:45 PM View: | Sandborn William J. See Remarks | Ventyx Biosciences, Inc. (VTYX) | 31-Aug-23 | Option Exercise | 11,900 | $14.85 | $176,715.00 | 16% 72.58K to 84.48K | 8% |
| 01-Sep-23 4:45 PM View: | Sandborn William J. See Remarks | Ventyx Biosciences, Inc. (VTYX) | 31-Aug-23 | Planned Private Option Sale | 11,900 | $33.64 | $400,354.00 | (14%) 84.48K to 72.58K | |
| 08-Aug-23 6:57 PM View: | Sandborn William J. See Remarks | Ventyx Biosciences, Inc. (VTYX) | 08-Aug-23 | Private Sale (Planned) | 3,494 | $32.86 | $114,810.00 | (5%) 76.08K to 72.58K | |
| 08-Aug-23 6:54 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 07-Aug-23 | Planned Option Sale | 30,000 | $33.52 | $1,005,570.00 | (2%) 1.54M to 1.51M | |
| 08-Aug-23 6:54 PM View: | Mohan Raju Chief Executive Officer Director | Ventyx Biosciences, Inc. (VTYX) | 07-Aug-23 | Option Exercise | 30,000 | $8.04 | $241,200.00 | 2% 1.51M to 1.54M | |
| 04-Aug-23 6:06 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Aug-23 | Option Exercise | 15,000 | $8.04 | $120,600.00 | 5% 276.55K to 291.55K | |
| 04-Aug-23 6:08 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Aug-23 | Planned Option Sale | 10,000 | $35.60 | $355,986.00 | (4%) 254.81K to 244.81K | |
| 04-Aug-23 6:06 PM View: | Krueger Christopher W Chief Business Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Aug-23 | Planned Option Sale | 15,000 | $35.59 | $533,797.00 | (5%) 291.55K to 276.55K | |
| 04-Aug-23 6:08 PM View: | Nuss John Chief Scientific Officer | Ventyx Biosciences, Inc. (VTYX) | 03-Aug-23 | Option Exercise | 10,000 | $0.20 | $2,000.00 | 4% 244.81K to 254.81K | |
| 01-Aug-23 5:43 PM View: | Nsv Partners III Lp 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 31-Jul-23 | Sale (Planned) | 10,803 | $37.59 | $406,035.00 | (< 1%) 17.11M to 17.1M | |
| 01-Aug-23 5:44 PM View: | Subramaniam Somu Director 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 31-Jul-23 | Sale (Planned) Duplicate | 10,803 | $37.59 | $406,035.00 | (< 1%) 17.11M to 17.1M | |
| 01-Aug-23 4:21 PM View: | Sandborn William J. See Remarks | Ventyx Biosciences, Inc. (VTYX) | 31-Jul-23 | Planned Private Option Sale | 11,900 | $37.16 | $442,261.00 | (14%) 87.98K to 76.08K | |
| 01-Aug-23 4:21 PM View: | Sandborn William J. See Remarks | Ventyx Biosciences, Inc. (VTYX) | 31-Jul-23 | Option Exercise | 11,900 | $14.85 | $176,715.00 | 16% 76.08K to 87.98K | 8% |
| 01-Aug-23 5:43 PM View: | Nsv Partners III Lp 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 28-Jul-23 | Private Sale (Planned) | 611 | $37.53 | $22,932.70 | (< 1%) 17.11M to 17.11M | |
| 01-Aug-23 5:44 PM View: | Subramaniam Somu Director 10% Owner | Ventyx Biosciences, Inc. (VTYX) | 28-Jul-23 | Private Sale (Planned) Duplicate | 611 | $37.53 | $22,932.70 | (< 1%) 17.11M to 17.11M | |
| 26-Jul-23 6:51 PM View: | Auster Martin Chief Financial Officer | Ventyx Biosciences, Inc. (VTYX) | 25-Jul-23 | Planned Option Sale | 28,000 | $35.54 | $995,044.00 | (37%) 75.65K to 47.65K | |
| 26-Jul-23 6:51 PM View: | Auster Martin Chief Financial Officer | Ventyx Biosciences, Inc. (VTYX) | 25-Jul-23 | Option Exercise | 28,000 | $3.45 | $96,600.00 | 59% 47.65K to 75.65K |
